CA3234498A1 - Method for producing compound or pharmaceutically acceptable salt thereof - Google Patents
Method for producing compound or pharmaceutically acceptable salt thereof Download PDFInfo
- Publication number
- CA3234498A1 CA3234498A1 CA3234498A CA3234498A CA3234498A1 CA 3234498 A1 CA3234498 A1 CA 3234498A1 CA 3234498 A CA3234498 A CA 3234498A CA 3234498 A CA3234498 A CA 3234498A CA 3234498 A1 CA3234498 A1 CA 3234498A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- crystal
- synthesizing
- reaction
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021164171 | 2021-10-05 | ||
| JP2021-164171 | 2021-10-05 | ||
| PCT/JP2022/037098 WO2023058645A1 (ja) | 2021-10-05 | 2022-10-04 | 化合物又はその薬学的に許容される塩の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3234498A1 true CA3234498A1 (en) | 2023-04-13 |
Family
ID=85803498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3234498A Pending CA3234498A1 (en) | 2021-10-05 | 2022-10-04 | Method for producing compound or pharmaceutically acceptable salt thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240262805A1 (https=) |
| EP (1) | EP4414362A4 (https=) |
| JP (1) | JPWO2023058645A1 (https=) |
| KR (1) | KR20240073943A (https=) |
| CN (1) | CN118055925A (https=) |
| AU (1) | AU2022361862A1 (https=) |
| CA (1) | CA3234498A1 (https=) |
| IL (1) | IL311879A (https=) |
| MX (1) | MX2024004049A (https=) |
| TW (1) | TW202330490A (https=) |
| WO (1) | WO2023058645A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116947658B (zh) * | 2023-07-28 | 2025-10-28 | 南通华祥医药科技有限公司 | 一种1-氨基-2-甲基-2-丙醇的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3269772B1 (en) * | 2015-03-10 | 2020-11-11 | Unimatec Co., Ltd. | Fluorine-containing boric acid/pvb composite |
| ES2856125T3 (es) | 2016-02-05 | 2021-09-27 | Ea Pharma Co Ltd | Derivado de sulfonamida y composición farmacéutica que contiene la misma |
| TW201731824A (zh) * | 2016-02-05 | 2017-09-16 | Ea Pharma Co Ltd | α４β７整合蛋白抑制劑 |
| JP2019031449A (ja) * | 2017-08-04 | 2019-02-28 | Ｅａファーマ株式会社 | スルホンアミド誘導体及びそれを含有する医薬組成物 |
-
2022
- 2022-10-04 WO PCT/JP2022/037098 patent/WO2023058645A1/ja not_active Ceased
- 2022-10-04 AU AU2022361862A patent/AU2022361862A1/en active Pending
- 2022-10-04 CA CA3234498A patent/CA3234498A1/en active Pending
- 2022-10-04 TW TW111137652A patent/TW202330490A/zh unknown
- 2022-10-04 EP EP22878513.5A patent/EP4414362A4/en active Pending
- 2022-10-04 JP JP2023552896A patent/JPWO2023058645A1/ja active Pending
- 2022-10-04 MX MX2024004049A patent/MX2024004049A/es unknown
- 2022-10-04 CN CN202280067043.4A patent/CN118055925A/zh active Pending
- 2022-10-04 KR KR1020247014478A patent/KR20240073943A/ko active Pending
- 2022-10-04 IL IL311879A patent/IL311879A/en unknown
-
2024
- 2024-04-02 US US18/624,295 patent/US20240262805A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4414362A4 (en) | 2025-09-03 |
| IL311879A (en) | 2024-06-01 |
| WO2023058645A1 (ja) | 2023-04-13 |
| AU2022361862A1 (en) | 2024-04-18 |
| JPWO2023058645A1 (https=) | 2023-04-13 |
| KR20240073943A (ko) | 2024-05-27 |
| CN118055925A (zh) | 2024-05-17 |
| US20240262805A1 (en) | 2024-08-08 |
| MX2024004049A (es) | 2024-04-25 |
| TW202330490A (zh) | 2023-08-01 |
| EP4414362A1 (en) | 2024-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2619374T3 (es) | Procedimiento de preparación de sal derivada de diamina ópticamente activa | |
| JP2024503855A (ja) | アミノピリミジン系ｆａｋ阻害剤化合物を合成する方法 | |
| US20220127259A1 (en) | Solid state forms of valbenazine | |
| EP1478619B1 (en) | A process for preparing a phenylalanine derivative and intermediates thereof | |
| JP6862354B2 (ja) | ナイトロジェンマスタード誘導体の調製方法 | |
| US20240262805A1 (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| AU2014236502A1 (en) | Processes for producing Sovaprevir | |
| JP2002502378A (ja) | グアニジル化試薬 | |
| AU2021374232A1 (en) | Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof | |
| HK40111936A (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| HK40106397A (zh) | 化合物或其药学上允许的盐的制造方法 | |
| CN114394969A (zh) | 一种培哚普利杂质k的制备方法 | |
| CZ2003165A3 (cs) | Způsob přípravy solí 5-fenylpentanoyl-(S)-alanyl-(S)-arginyl-(S)-alanyl-{(S)-2-[(R)-3-amino-2-oxopyrrolidin-1-yl]propionyl}-(S)-alanyl-(S)-arginyl-(S)-alanyl-4-aminofenylacetamidu | |
| JPH078855B2 (ja) | スルホニウム化合物 | |
| CN105121417B (zh) | 经取代噻唑基乙酸三乙胺盐的结晶型 | |
| CN112552374B (zh) | 一种肽酰胺类化合物及其中间体的制备方法 | |
| CA2720312A1 (en) | Methods for making 4-tetrazolyl-4-phenylpiperidine compounds | |
| TWI868287B (zh) | carba-環狀磷脂酸化合物 | |
| WO2026075272A1 (ja) | ２－オキソイミダゾールジペプチド又はその塩の製造方法及びその結晶形 | |
| CN120098068A (zh) | 一种醋酸地非法林的制备方法 | |
| EP3480195A1 (en) | Method for the synthesis of cyclic depsipeptides | |
| JPH0714906B2 (ja) | 保護アミノ酸の生成方法 | |
| WO2006080484A1 (ja) | セフカペン ピボキシルのメタンスルホン酸塩 | |
| HK1250732B (en) | Process for preparation of nitrogen mustard derivatives | |
| WO2016145269A1 (en) | Solid state forms ledipasvir and processes for preparation of ledipasvir |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240823 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240823 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240923 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240923 |